Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II：A Randomized Controlled Open-label Clinical Trial

NCT04617561 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04617561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II：A Randomized Controlled Open-label Clinical Trial
Lead sponsor
West China Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 1, 2022
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis, autoimmune, primary biliary cholangitis